葛兰素史克的哮喘药物Nucala获FDA批准用于治疗 "吸烟者肺病

路透中文
23 May
<a href="https://laohu8.com/S/GSK">葛兰素史克</a>的哮喘药物Nucala获FDA批准用于治疗 "吸烟者肺病

路透5月22日 - 美国食品和药物管理局已批准英国制药商葛兰素史克公司(GSK.L)的哮喘药物用于治疗一些慢性肺病患者,这种慢性肺病通常被称为 "吸烟者之肺"。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10